CLC bio Bridges Digital and Analogue Gene Expression with new Version of CLC Genomics Workbench
News Jan 28, 2009
CLC bio has released version 3.0 of their solution for analyzing and visualizing Next Generation Sequencing data, CLC Genomics Workbench.
The new version is crammed with features like digital gene expression, expression analysis of micro arrays and RNA-seq data – and an overhauled long reads assembler which is said to be up to 15 times faster than the previous version.
"With this release we deliver the world's first complete cross-platform solution which combines Expression Analyzes with Next Generation Sequencing, thereby building a bridge between digital and analogue gene expression" states Dr. Roald Forsberg, Director of Scientific Solutions at CLC bio.
Dr. Forsberg continues, "Furthermore, we embrace the fact that the NGS vendors continually are providing longer and longer reads, and to fully utilize that potential we have improved our assembler for long reads, so it's now up 15 times faster and delivers more precise results compared to short read assembly."
According to Company, CLC Genomics Workbench is the first and only comprehensive analysis package, which can analyze and visualize data from all major Next Generation Sequencing platforms. CLC Genomics Workbench is platform independent, running on Mac OS X, Windows, and Linux - including 64bit versions.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE